J Trent Magruder1, Todd C Crawford1, Herbert Lynn Harness1, Joshua C Grimm1, Alejandro Suarez-Pierre1, Chad Wierschke1, Jim Biewer1, Charles Hogue2, Glenn R Whitman1, Ashish S Shah3, Viachaslau Barodka4. 1. Division of Cardiac Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Md. 2. Division of Cardiac Anesthesia, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Md. 3. Department of Cardiac Surgery, Vanderbilt University School of Medicine, Nashville, Tenn. 4. Division of Cardiac Anesthesia, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Md. Electronic address: vbarodk1@jhmi.edu.
Abstract
BACKGROUND: We sought to determine whether a pilot goal-directed perfusion initiative could reduce the incidence of acute kidney injury after cardiac surgery. METHODS: On the basis of the available literature, we identified goals to achieve during cardiopulmonary bypass (including maintenance of oxygen delivery >300 mL O2/min/m2 and reduction in vasopressor use) that were combined into a goal-directed perfusion initiative and implemented as a quality improvement measure in patients undergoing cardiac surgery at Johns Hopkins during 2015. Goal-directed perfusion initiative patients were matched to controls who underwent cardiac surgery between 2010 and 2015 using propensity scoring across 15 variables. The primary and secondary outcomes were the incidence of acute kidney injury and the mean increase in serum creatinine within the first 72 hours after cardiac surgery. RESULTS: We used the goal-directed perfusion initiative in 88 patients and matched these to 88 control patients who were similar across all variables, including mean age (61 years in controls vs 64 years in goal-directed perfusion initiative patients, P = .12) and preoperative glomerular filtration rate (90 vs 83 mL/min, P = .34). Controls received more phenylephrine on cardiopulmonary bypass (mean 2.1 vs 1.4 mg, P < .001) and had lower nadir oxygen delivery (mean 241 vs 301 mL O2/min/m2, P < .001). Acute kidney injury incidence was 23.9% in controls and 9.1% in goal-directed perfusion initiative patients (P = .008); incidences of acute kidney injury stage 1, 2, and 3 were 19.3%, 3.4%, and 1.1% in controls, and 5.7%, 3.4%, and 0% in goal-directed perfusion initiative patients, respectively. Control patients exhibited a larger median percent increase in creatinine from baseline (27% vs 10%, P < .001). CONCLUSIONS: The goal-directed perfusion initiative was associated with reduced acute kidney injury incidence after cardiac surgery in this pilot study.
BACKGROUND: We sought to determine whether a pilot goal-directed perfusion initiative could reduce the incidence of acute kidney injury after cardiac surgery. METHODS: On the basis of the available literature, we identified goals to achieve during cardiopulmonary bypass (including maintenance of oxygen delivery >300 mL O2/min/m2 and reduction in vasopressor use) that were combined into a goal-directed perfusion initiative and implemented as a quality improvement measure in patients undergoing cardiac surgery at Johns Hopkins during 2015. Goal-directed perfusion initiative patients were matched to controls who underwent cardiac surgery between 2010 and 2015 using propensity scoring across 15 variables. The primary and secondary outcomes were the incidence of acute kidney injury and the mean increase in serum creatinine within the first 72 hours after cardiac surgery. RESULTS: We used the goal-directed perfusion initiative in 88 patients and matched these to 88 control patients who were similar across all variables, including mean age (61 years in controls vs 64 years in goal-directed perfusion initiative patients, P = .12) and preoperative glomerular filtration rate (90 vs 83 mL/min, P = .34). Controls received more phenylephrine on cardiopulmonary bypass (mean 2.1 vs 1.4 mg, P < .001) and had lower nadir oxygen delivery (mean 241 vs 301 mL O2/min/m2, P < .001). Acute kidney injury incidence was 23.9% in controls and 9.1% in goal-directed perfusion initiative patients (P = .008); incidences of acute kidney injury stage 1, 2, and 3 were 19.3%, 3.4%, and 1.1% in controls, and 5.7%, 3.4%, and 0% in goal-directed perfusion initiative patients, respectively. Control patients exhibited a larger median percent increase in creatinine from baseline (27% vs 10%, P < .001). CONCLUSIONS: The goal-directed perfusion initiative was associated with reduced acute kidney injury incidence after cardiac surgery in this pilot study.
Authors: M Czerny; H Baumer; J Kilo; A Lassnigg; A Hamwi; T Vukovich; E Wolner; M Grimm Journal: Eur J Cardiothorac Surg Date: 2000-06 Impact factor: 4.191
Authors: P Tassani; J A Richter; G P Eising; A Barankay; S L Braun; C H Haehnel; P Spaeth; H Schad; H Meisner Journal: J Cardiothorac Vasc Anesth Date: 1999-06 Impact factor: 2.628
Authors: Daijiro Hori; Allen D Everett; Jennifer K Lee; Masahiro Ono; Charles H Brown; Ashish S Shah; Kaushik Mandal; Joel E Price; Laeben C Lester; Charles W Hogue Journal: Ann Thorac Surg Date: 2015-07-07 Impact factor: 4.330
Authors: Alina M Grigore; Hilary P Grocott; Joseph P Mathew; Barbara Phillips-Bute; Timothy O Stanley; Aimee Butler; Kevin P Landolfo; Joseph G Reves; James A Blumenthal; Mark F Newman Journal: Anesth Analg Date: 2002-01 Impact factor: 5.108
Authors: Theron A Paugh; Timothy A Dickinson; James R Martin; Eric C Hanson; John Fuller; Michael Heung; Min Zhang; Kenneth G Shann; Richard L Prager; Donald S Likosky Journal: Ann Thorac Surg Date: 2015-07-22 Impact factor: 4.330
Authors: E Sirvinskas; J Andrejaitiene; L Raliene; L Nasvytis; A Karbonskiene; V Pilvinis; J Sakalauskas Journal: Perfusion Date: 2008-11 Impact factor: 1.972
Authors: Elsayed Elmistekawy; Bernard McDonald; Christopher Hudson; Marc Ruel; Thierry Mesana; Vincent Chan; Munir Boodhwani Journal: Ann Thorac Surg Date: 2014-07-31 Impact factor: 4.330
Authors: Hussam Al Hussein; Hamida Al Hussein; Carmen Sircuta; Ovidiu S Cotoi; Ionela Movileanu; Dan Nistor; Bogdan Cordos; Radu Deac; Horatiu Suciu; Klara Brinzaniuc; Dan T Simionescu; Marius M Harpa Journal: Tissue Eng Regen Med Date: 2020-08-29 Impact factor: 4.169
Authors: Alfred H Stammers; Eric A Tesdahl; Linda B Mongero; Kirti P Patel; Courtney C Petersen; Jennifer Arriola Vucovich; Jeffrey P Jacobs Journal: J Extra Corpor Technol Date: 2021-03
Authors: Mark Broadwin; Monica Palmeri; Tyler Kelting; Robert Groom; Michael Robich; F Lee Lucas; Robert Kramer Journal: J Extra Corpor Technol Date: 2022-06
Authors: Bradford B Smith; William J Mauermann; Suraj M Yalamuri; Ryan D Frank; Carmelina Gurrieri; Arman Arghami; Mark M Smith Journal: Ann Thorac Surg Date: 2020-03-07 Impact factor: 4.330